0001883744-21-000001.txt : 20210917
0001883744-21-000001.hdr.sgml : 20210917
20210917150103
ACCESSION NUMBER: 0001883744-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210917
DATE AS OF CHANGE: 20210917
EFFECTIVENESS DATE: 20210917
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NapaJen Pharma, Inc.
CENTRAL INDEX KEY: 0001883744
IRS NUMBER: 201993612
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-413786
FILM NUMBER: 211260106
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BOULEVARD, SUITE 527
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 81-42-316-6773
MAIL ADDRESS:
STREET 1: 533 AIRPORT BOULEVARD, SUITE 527
CITY: BURLINGAME
STATE: CA
ZIP: 94010
D
1
primary_doc.xml
X0708
D
LIVE
0001883744
NapaJen Pharma, Inc.
533 AIRPORT BOULEVARD, SUITE 527
BURLINGAME
CA
CALIFORNIA
94010
81-42-316-6773
CALIFORNIA
None
None
Corporation
true
Walter
Olesiak
c/o NapaJen Pharma, Inc.
533 Airport Boulevard, Suite 527
Burlingame
CA
CALIFORNIA
94010
Executive Officer
Director
Taro
Inaba
c/o NapaJen Pharma, Inc.
533 Airport Boulevard, Suite 527
Burlingame
CA
CALIFORNIA
94010
Director
Kazuhiko
Nonomura
c/o NapaJen Pharma, Inc.
533 Airport Boulevard, Suite 527
Burlingame
CA
CALIFORNIA
94010
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-08-24
false
true
false
0
2000000
500000
1500000
false
1
0
0
0
false
NapaJen Pharma, Inc.
/s/ Walter Olesiak
Walter Olesiak
Chief Executive Officer
2021-09-14